InvestorsHub Logo
Followers 58
Posts 10035
Boards Moderated 1
Alias Born 09/21/2016

Re: abew4me post# 364829

Friday, 07/01/2022 6:56:17 AM

Friday, July 01, 2022 6:56:17 AM

Post# of 458299

NeuroSense Therapeutics Reports Positive Preliminary Results from Novel Alzheimer's Biomarker Study
Jun 30, 2022, 08:30 ET

[NRSN is up over 250% in the last 3 days]

Biomarkers show the potential of NeuroSense's combination drug CogniC to treat Alzheimer's disease
CogniC is expected to advance into clinical trials in 2023



Very interesting and NO CONTRADICTIONS w/AVXL MOA findings noted.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News